Corrigendum: Isoliquiritigenin Protects Against Pancreatic Injury and Intestinal Dysfunction After Severe Acute Pancreatitis via Nrf2 Signaling

Detalles Bibliográficos
Autores principales: Zhang, Man, Wu, Yan-Qing, Xie, Ling, Wu, Jiang, Xu, Ke, Xiao, Jian, Chen, Da-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640117/
https://www.ncbi.nlm.nih.gov/pubmed/31354498
http://dx.doi.org/10.3389/fphar.2019.00788
_version_ 1783436589073956864
author Zhang, Man
Wu, Yan-Qing
Xie, Ling
Wu, Jiang
Xu, Ke
Xiao, Jian
Chen, Da-Qing
author_facet Zhang, Man
Wu, Yan-Qing
Xie, Ling
Wu, Jiang
Xu, Ke
Xiao, Jian
Chen, Da-Qing
author_sort Zhang, Man
collection PubMed
description
format Online
Article
Text
id pubmed-6640117
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66401172019-07-26 Corrigendum: Isoliquiritigenin Protects Against Pancreatic Injury and Intestinal Dysfunction After Severe Acute Pancreatitis via Nrf2 Signaling Zhang, Man Wu, Yan-Qing Xie, Ling Wu, Jiang Xu, Ke Xiao, Jian Chen, Da-Qing Front Pharmacol Pharmacology Frontiers Media S.A. 2019-07-12 /pmc/articles/PMC6640117/ /pubmed/31354498 http://dx.doi.org/10.3389/fphar.2019.00788 Text en Copyright © 2019 Zhang, Wu, Xie, Wu, Xu, Xiao and Chen http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zhang, Man
Wu, Yan-Qing
Xie, Ling
Wu, Jiang
Xu, Ke
Xiao, Jian
Chen, Da-Qing
Corrigendum: Isoliquiritigenin Protects Against Pancreatic Injury and Intestinal Dysfunction After Severe Acute Pancreatitis via Nrf2 Signaling
title Corrigendum: Isoliquiritigenin Protects Against Pancreatic Injury and Intestinal Dysfunction After Severe Acute Pancreatitis via Nrf2 Signaling
title_full Corrigendum: Isoliquiritigenin Protects Against Pancreatic Injury and Intestinal Dysfunction After Severe Acute Pancreatitis via Nrf2 Signaling
title_fullStr Corrigendum: Isoliquiritigenin Protects Against Pancreatic Injury and Intestinal Dysfunction After Severe Acute Pancreatitis via Nrf2 Signaling
title_full_unstemmed Corrigendum: Isoliquiritigenin Protects Against Pancreatic Injury and Intestinal Dysfunction After Severe Acute Pancreatitis via Nrf2 Signaling
title_short Corrigendum: Isoliquiritigenin Protects Against Pancreatic Injury and Intestinal Dysfunction After Severe Acute Pancreatitis via Nrf2 Signaling
title_sort corrigendum: isoliquiritigenin protects against pancreatic injury and intestinal dysfunction after severe acute pancreatitis via nrf2 signaling
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640117/
https://www.ncbi.nlm.nih.gov/pubmed/31354498
http://dx.doi.org/10.3389/fphar.2019.00788
work_keys_str_mv AT zhangman corrigendumisoliquiritigeninprotectsagainstpancreaticinjuryandintestinaldysfunctionaftersevereacutepancreatitisvianrf2signaling
AT wuyanqing corrigendumisoliquiritigeninprotectsagainstpancreaticinjuryandintestinaldysfunctionaftersevereacutepancreatitisvianrf2signaling
AT xieling corrigendumisoliquiritigeninprotectsagainstpancreaticinjuryandintestinaldysfunctionaftersevereacutepancreatitisvianrf2signaling
AT wujiang corrigendumisoliquiritigeninprotectsagainstpancreaticinjuryandintestinaldysfunctionaftersevereacutepancreatitisvianrf2signaling
AT xuke corrigendumisoliquiritigeninprotectsagainstpancreaticinjuryandintestinaldysfunctionaftersevereacutepancreatitisvianrf2signaling
AT xiaojian corrigendumisoliquiritigeninprotectsagainstpancreaticinjuryandintestinaldysfunctionaftersevereacutepancreatitisvianrf2signaling
AT chendaqing corrigendumisoliquiritigeninprotectsagainstpancreaticinjuryandintestinaldysfunctionaftersevereacutepancreatitisvianrf2signaling

Ejemplares similares